Axol Bioscience, which has facilities in Cambridge and Edinburgh, has raised $2.8 million (£2.1m) funding to accelerate product development, scale up cell manufacturing and progress US expansion plans ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results